Inventor
LOPEZ-TAPIA FRANCISCO JAVIER
US38 patents
⚠️ This page may combine multiple inventors who share the name “LOPEZ-TAPIA FRANCISCO JAVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
14 patentsUS8940741B2Jan 27, 2015
Inhibitors of bruton's tyrosine kinase
HOFFMANN LA ROCHE4 citations71
US11104668B2Aug 31, 2021
Inhibitors of bruton's tyrosine kinase
HOFFMANN LA ROCHE0 citations62
US8742098B2Jun 3, 2014
Inhibitors of Bruton's tyrosine kinase
HOFFMANN LA ROCHE2 citations62
US9802920B2Oct 31, 2017
Inhibitors of bruton's tyrosine kinase
HOFFMANN LA ROCHE0 citations52
US9663494B2May 30, 2017
Inhibitors of bruton's tyrosine kinase
HOFFMANN LA ROCHE0 citations52
US9469644B2Oct 18, 2016
Inhibitors of Bruton's tyrosine kinase
HOFFMANN LA ROCHE1 citations52
US10640491B2May 5, 2020
Inhibitors of bruton's tyrosine kinase
HOFFMANN LA ROCHE0 citations51
US10093657B2Oct 9, 2018
Inhibitors of bruton's tyrosine kinase
HOFFMANN LA ROCHE0 citations51
US9624201B2Apr 18, 2017
Inhibitors of bruton's tyrosine kinase
HOFFMANN LA ROCHE0 citations51
US9556147B2Jan 31, 2017
Inhibitors of bruton's tyrosine kinase
HOFFMANN LA ROCHE0 citations51
US9458105B2Oct 4, 2016
Inhibitors of Bruton's tyrosine kinase
HOFFMANN LA ROCHE1 citations51
US9359345B2Jun 7, 2016
Thiazole derivatives as inhibitors of Bruton's tyrosine kinase
HOFFMANN LA ROCHE1 citations46
US9556150B2Jan 31, 2017
Inhibitors of bruton's tyrosine kinase
HOFFMANN LA ROCHE0 citations41
US9499548B2Nov 22, 2016
Inhibitors of bruton's tyrosine kinase
HOFFMANN LA ROCHE0 citations39
ROCHE PALO ALTO LLC
8 patentsUS6998414B2Feb 14, 2006
Substituted arylamides as IP antagonists
ROCHE PALO ALTO LLC6 citations73
US6569860B2May 27, 2003
Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as IP antagonists
ROCHE PALO ALTO LLC11 citations72
US7141584B2Nov 28, 2006
2-(substituted-phenyl)amino-imidazoline derivatives
ROCHE PALO ALTO LLC3 citations61
US7776910B2Aug 17, 2010
Arylsulfonyl pyrrolidines as 5-HT6 inhibitors
ROCHE PALO ALTO LLC3 citations60
US8372865B2Feb 12, 2013
Dihydropyridone amides as P2X7 modulators
ROCHE PALO ALTO LLC0 citations51
US7279498B2Oct 9, 2007
Substituted aryl amides as IP antagonists
ROCHE PALO ALTO LLC1 citations51
US7244738B2Jul 17, 2007
Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists
ROCHE PALO ALTO LLC1 citations50
US7754759B2Jul 13, 2010
Arylsulfonyl chromans as 5-HT6 inhibitors
ROCHE PALO ALTO LLC0 citations40
SYNTEX LLC
5 patentsUS6903086B2Jun 7, 2005
Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists
SYNTEX LLC16 citations83
US6335459B1Jan 1, 2002
Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
SYNTEX LLC9 citations71
US6693200B2Feb 17, 2004
2-(substituted-phenyl)amino-imidazoline derivatives
SYNTEX LLC1 citations61
US6596876B2Jul 22, 2003
2-(substituted-phenyl)amino-imidazoline derivatives
SYNTEX LLC3 citations61
US6472536B1Oct 29, 2002
2-(substituted-phenyl)amino-imidazoline derivatives
SYNTEX LLC3 citations61
BROTHERTON-PLEISS CHRISTINE E
4 patentsUS8889682B2Nov 18, 2014
Inhibitors of bruton'S tyrosine kinase
BROTHERTON-PLEISS CHRISTINE E8 citations82
US8871760B2Oct 28, 2014
[1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
BROTHERTON-PLEISS CHRISTINE E19 citations81
US8153809B2Apr 10, 2012
Dihydropyridone ureas as P2X7 modulators
BROTHERTON-PLEISS CHRISTINE E0 citations49
US8435990B2May 7, 2013
Dihydropyrimidone amides as P2X7 modulators
BROTHERTON-PLEISS CHRISTINE E0 citations39